Walvax沃森生物

CN
EN

Help Everyone Live a Healthy Life

Investors

Walvax aims to become a high-quality, cost-effective and sustainable global vaccine producer. 

R&D

We have abundant blockbuster pipelines in clinical stage, and keep investing a significant amount of revenue into R&D.  

Products

We have successfully developed and licensed 7 vaccines and protected hundreds of millions of people from diseases. 

About Walvax

Founded in 2001, Walvax is mainly engaged in research and development, manufacturing and distribution of safe and efficacious vaccines. With the purpose of “Help everyone live a healthy life”, Walvax aims to be a leader in public health, sustainably providing high-quality and innovative products to protect against the world’s deadliest diseases.

Learn More
459.2
USD459.2 million revenue in 2020
162.1%
162.1% increase in revenue since 2019
8
8 new vaccines and 1 siRNA therapeutics under development
65
65 authorized invention patents at home and abroad
10+
10+ patents application in progress
94.6%
94.6% cities covered in China
15
Products exported to 15 countries
24
24 countries registration in progress
40
Engaged 40 partners in 5 continents

Join Us

You’ll partner with colleagues of diverse backgrounds and abilities. 

Responsibility

We are focused on the areas of greatest need.